CA2986467C - Systems and methods for treatment of urinary dysfunction - Google Patents
Systems and methods for treatment of urinary dysfunction Download PDFInfo
- Publication number
- CA2986467C CA2986467C CA2986467A CA2986467A CA2986467C CA 2986467 C CA2986467 C CA 2986467C CA 2986467 A CA2986467 A CA 2986467A CA 2986467 A CA2986467 A CA 2986467A CA 2986467 C CA2986467 C CA 2986467C
- Authority
- CA
- Canada
- Prior art keywords
- stimulation
- nerve
- stimulator
- patient
- ipc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000011282 treatment Methods 0.000 title claims description 223
- 230000002485 urinary effect Effects 0.000 title claims description 17
- 230000004064 dysfunction Effects 0.000 title claims description 16
- 238000000034 method Methods 0.000 title abstract description 169
- 230000000638 stimulation Effects 0.000 claims abstract description 1248
- 210000005036 nerve Anatomy 0.000 claims abstract description 667
- 210000002972 tibial nerve Anatomy 0.000 claims abstract description 379
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 183
- 230000007383 nerve stimulation Effects 0.000 claims abstract description 113
- 210000003127 knee Anatomy 0.000 claims abstract description 40
- 230000003247 decreasing effect Effects 0.000 claims abstract description 24
- 210000003932 urinary bladder Anatomy 0.000 claims description 217
- 230000000694 effects Effects 0.000 claims description 184
- 230000004936 stimulating effect Effects 0.000 claims description 67
- 206010020853 Hypertonic bladder Diseases 0.000 claims description 63
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims description 62
- 208000020629 overactive bladder Diseases 0.000 claims description 62
- 238000002646 transcutaneous electrical nerve stimulation Methods 0.000 claims description 46
- 208000024891 symptom Diseases 0.000 claims description 41
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 37
- 230000007423 decrease Effects 0.000 claims description 36
- 208000035475 disorder Diseases 0.000 claims description 34
- 238000004891 communication Methods 0.000 claims description 33
- 210000003423 ankle Anatomy 0.000 claims description 29
- 208000002193 Pain Diseases 0.000 claims description 27
- 230000002401 inhibitory effect Effects 0.000 claims description 23
- 210000002414 leg Anatomy 0.000 claims description 23
- 230000036407 pain Effects 0.000 claims description 23
- 230000002964 excitative effect Effects 0.000 claims description 22
- 230000035807 sensation Effects 0.000 claims description 22
- 206010046555 Urinary retention Diseases 0.000 claims description 19
- 210000003141 lower extremity Anatomy 0.000 claims description 18
- 238000007920 subcutaneous administration Methods 0.000 claims description 16
- 238000011156 evaluation Methods 0.000 claims description 13
- 208000035824 paresthesia Diseases 0.000 claims description 11
- 210000003903 pelvic floor Anatomy 0.000 claims description 8
- 206010046543 Urinary incontinence Diseases 0.000 claims description 6
- 230000009172 bursting Effects 0.000 claims description 6
- 206010069632 Bladder dysfunction Diseases 0.000 claims description 5
- 230000003993 interaction Effects 0.000 claims description 5
- 210000003752 saphenous vein Anatomy 0.000 claims description 5
- 208000034347 Faecal incontinence Diseases 0.000 claims description 4
- 208000029162 bladder disease Diseases 0.000 claims description 4
- 208000000450 Pelvic Pain Diseases 0.000 claims description 3
- 206010066218 Stress Urinary Incontinence Diseases 0.000 claims description 3
- 208000022170 stress incontinence Diseases 0.000 claims description 3
- 201000001880 Sexual dysfunction Diseases 0.000 claims 2
- 231100000872 sexual dysfunction Toxicity 0.000 claims 2
- 208000026533 urinary bladder disease Diseases 0.000 claims 1
- 230000004913 activation Effects 0.000 abstract description 87
- 230000001537 neural effect Effects 0.000 abstract description 70
- 230000005284 excitation Effects 0.000 abstract description 34
- 238000005516 engineering process Methods 0.000 abstract description 15
- 239000000758 substrate Substances 0.000 abstract description 11
- 208000014001 urinary system disease Diseases 0.000 abstract description 4
- 238000012369 In process control Methods 0.000 description 594
- 238000004190 ion pair chromatography Methods 0.000 description 594
- 210000004544 dc2 Anatomy 0.000 description 583
- 210000001519 tissue Anatomy 0.000 description 164
- 230000004044 response Effects 0.000 description 126
- 238000001994 activation Methods 0.000 description 86
- 230000008901 benefit Effects 0.000 description 68
- 238000012216 screening Methods 0.000 description 68
- 230000001965 increasing effect Effects 0.000 description 66
- 230000001225 therapeutic effect Effects 0.000 description 66
- 230000001154 acute effect Effects 0.000 description 59
- 206010001497 Agitation Diseases 0.000 description 57
- 230000001976 improved effect Effects 0.000 description 48
- 230000005764 inhibitory process Effects 0.000 description 46
- 230000002035 prolonged effect Effects 0.000 description 46
- 210000002683 foot Anatomy 0.000 description 36
- 230000006870 function Effects 0.000 description 35
- 239000007943 implant Substances 0.000 description 35
- 241000700159 Rattus Species 0.000 description 34
- 238000002513 implantation Methods 0.000 description 34
- 210000000273 spinal nerve root Anatomy 0.000 description 31
- 230000008859 change Effects 0.000 description 30
- 230000000763 evoking effect Effects 0.000 description 29
- 238000013461 design Methods 0.000 description 28
- 239000000835 fiber Substances 0.000 description 28
- 238000005094 computer simulation Methods 0.000 description 27
- 210000000578 peripheral nerve Anatomy 0.000 description 27
- 230000005684 electric field Effects 0.000 description 26
- 238000002474 experimental method Methods 0.000 description 25
- 230000003213 activating effect Effects 0.000 description 24
- 239000003814 drug Substances 0.000 description 24
- 230000037361 pathway Effects 0.000 description 24
- 229940079593 drug Drugs 0.000 description 23
- 238000012360 testing method Methods 0.000 description 23
- 239000000463 material Substances 0.000 description 22
- 210000001699 lower leg Anatomy 0.000 description 21
- 238000010586 diagram Methods 0.000 description 20
- 210000003205 muscle Anatomy 0.000 description 19
- 238000002604 ultrasonography Methods 0.000 description 19
- 210000001186 vagus nerve Anatomy 0.000 description 18
- 210000004556 brain Anatomy 0.000 description 17
- 230000008602 contraction Effects 0.000 description 17
- 230000004007 neuromodulation Effects 0.000 description 16
- 230000011514 reflex Effects 0.000 description 16
- 230000001953 sensory effect Effects 0.000 description 16
- 239000004020 conductor Substances 0.000 description 15
- 230000002093 peripheral effect Effects 0.000 description 15
- 230000002829 reductive effect Effects 0.000 description 15
- 238000004088 simulation Methods 0.000 description 15
- 238000002651 drug therapy Methods 0.000 description 13
- 230000003287 optical effect Effects 0.000 description 13
- 238000005259 measurement Methods 0.000 description 12
- 230000002708 enhancing effect Effects 0.000 description 11
- 230000005012 migration Effects 0.000 description 11
- 238000013508 migration Methods 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 238000012545 processing Methods 0.000 description 11
- 230000009467 reduction Effects 0.000 description 11
- 230000000007 visual effect Effects 0.000 description 11
- 208000004168 Underactive Urinary Bladder Diseases 0.000 description 10
- 238000013459 approach Methods 0.000 description 10
- 230000001684 chronic effect Effects 0.000 description 10
- 230000006690 co-activation Effects 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 238000002347 injection Methods 0.000 description 10
- 230000033001 locomotion Effects 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 10
- 210000004126 nerve fiber Anatomy 0.000 description 10
- 210000000944 nerve tissue Anatomy 0.000 description 10
- 238000000576 coating method Methods 0.000 description 9
- 230000001276 controlling effect Effects 0.000 description 9
- 238000003384 imaging method Methods 0.000 description 9
- 230000006698 induction Effects 0.000 description 9
- 230000004048 modification Effects 0.000 description 9
- 238000012986 modification Methods 0.000 description 9
- 210000001428 peripheral nervous system Anatomy 0.000 description 9
- 210000001032 spinal nerve Anatomy 0.000 description 9
- UELITFHSCLAHKR-UHFFFAOYSA-N acibenzolar-S-methyl Chemical compound CSC(=O)C1=CC=CC2=C1SN=N2 UELITFHSCLAHKR-UHFFFAOYSA-N 0.000 description 8
- 230000008878 coupling Effects 0.000 description 8
- 238000010168 coupling process Methods 0.000 description 8
- 238000005859 coupling reaction Methods 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 230000007774 longterm Effects 0.000 description 8
- 210000000278 spinal cord Anatomy 0.000 description 8
- 206010019233 Headaches Diseases 0.000 description 7
- 241000282412 Homo Species 0.000 description 7
- 208000019695 Migraine disease Diseases 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 206010015037 epilepsy Diseases 0.000 description 7
- 210000003099 femoral nerve Anatomy 0.000 description 7
- 231100000869 headache Toxicity 0.000 description 7
- 238000012423 maintenance Methods 0.000 description 7
- 206010027599 migraine Diseases 0.000 description 7
- 238000007493 shaping process Methods 0.000 description 7
- 230000008093 supporting effect Effects 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 7
- 210000003371 toe Anatomy 0.000 description 7
- 230000001515 vagal effect Effects 0.000 description 7
- 206010021639 Incontinence Diseases 0.000 description 6
- 208000023610 Pelvic Floor disease Diseases 0.000 description 6
- 238000002648 combination therapy Methods 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- 210000004392 genitalia Anatomy 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 239000012811 non-conductive material Substances 0.000 description 6
- 230000007115 recruitment Effects 0.000 description 6
- 208000027765 speech disease Diseases 0.000 description 6
- 238000003491 array Methods 0.000 description 5
- 210000003169 central nervous system Anatomy 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000002354 daily effect Effects 0.000 description 5
- 238000011049 filling Methods 0.000 description 5
- 238000003306 harvesting Methods 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 210000000653 nervous system Anatomy 0.000 description 5
- 230000036961 partial effect Effects 0.000 description 5
- 230000006461 physiological response Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 230000002792 vascular Effects 0.000 description 5
- 108090000368 Fibroblast growth factor 8 Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108010057266 Type A Botulinum Toxins Proteins 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 210000000467 autonomic pathway Anatomy 0.000 description 4
- 210000003050 axon Anatomy 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 229940089093 botox Drugs 0.000 description 4
- 238000004422 calculation algorithm Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000003447 ipsilateral effect Effects 0.000 description 4
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 4
- 210000005230 lumbar spinal cord Anatomy 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 230000008035 nerve activity Effects 0.000 description 4
- 208000001797 obstructive sleep apnea Diseases 0.000 description 4
- 230000000737 periodic effect Effects 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 102000005162 pleiotrophin Human genes 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 239000011253 protective coating Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 230000000392 somatic effect Effects 0.000 description 4
- 210000005070 sphincter Anatomy 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 210000000689 upper leg Anatomy 0.000 description 4
- 230000007384 vagal nerve stimulation Effects 0.000 description 4
- 206010056948 Automatic bladder Diseases 0.000 description 3
- 208000000094 Chronic Pain Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010027566 Micturition urgency Diseases 0.000 description 3
- 239000004642 Polyimide Substances 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 210000003484 anatomy Anatomy 0.000 description 3
- 210000003403 autonomic nervous system Anatomy 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 210000002808 connective tissue Anatomy 0.000 description 3
- 210000003792 cranial nerve Anatomy 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- 230000002550 fecal effect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000001255 hallux Anatomy 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 230000003387 muscular Effects 0.000 description 3
- 230000001613 neoplastic effect Effects 0.000 description 3
- 210000000118 neural pathway Anatomy 0.000 description 3
- 230000010004 neural pathway Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229920001721 polyimide Polymers 0.000 description 3
- 230000009158 reflex pathway Effects 0.000 description 3
- 230000004043 responsiveness Effects 0.000 description 3
- 210000003497 sciatic nerve Anatomy 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 210000001590 sural nerve Anatomy 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 230000002889 sympathetic effect Effects 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 230000004797 therapeutic response Effects 0.000 description 3
- 238000011491 transcranial magnetic stimulation Methods 0.000 description 3
- 238000011269 treatment regimen Methods 0.000 description 3
- 210000003708 urethra Anatomy 0.000 description 3
- 230000001720 vestibular Effects 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010011953 Decreased activity Diseases 0.000 description 2
- 206010052804 Drug tolerance Diseases 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 229920000106 Liquid crystal polymer Polymers 0.000 description 2
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 2
- 208000028389 Nerve injury Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 206010036018 Pollakiuria Diseases 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000000921 Urge Urinary Incontinence Diseases 0.000 description 2
- 210000000579 abdominal fat Anatomy 0.000 description 2
- 230000036982 action potential Effects 0.000 description 2
- 238000011374 additional therapy Methods 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- 230000002567 autonomic effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000007012 clinical effect Effects 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000005574 cross-species transmission Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000009093 first-line therapy Methods 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000026781 habituation Effects 0.000 description 2
- 230000002489 hematologic effect Effects 0.000 description 2
- 230000000642 iatrogenic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000011810 insulating material Substances 0.000 description 2
- 238000007913 intrathecal administration Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000011866 long-term treatment Methods 0.000 description 2
- 238000009115 maintenance therapy Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000002161 motor neuron Anatomy 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 230000008764 nerve damage Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003071 parasitic effect Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920001643 poly(ether ketone) Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- -1 polytetrafluoroethylene Polymers 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000020431 spinal cord injury Diseases 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 210000002303 tibia Anatomy 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- ZNOCGWVLWPVKAO-UHFFFAOYSA-N trimethoxy(phenyl)silane Chemical compound CO[Si](OC)(OC)C1=CC=CC=C1 ZNOCGWVLWPVKAO-UHFFFAOYSA-N 0.000 description 2
- 210000001170 unmyelinated nerve fiber Anatomy 0.000 description 2
- 208000022934 urinary frequency Diseases 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 230000036318 urination frequency Effects 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- VRBFTYUMFJWSJY-UHFFFAOYSA-N 28804-46-8 Chemical compound ClC1CC(C=C2)=CC=C2C(Cl)CC2=CC=C1C=C2 VRBFTYUMFJWSJY-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000036829 Device dislocation Diseases 0.000 description 1
- 241001269524 Dura Species 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 208000030814 Eating disease Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 241000445129 Eremomyces bilateralis Species 0.000 description 1
- 101150096243 FENS gene Proteins 0.000 description 1
- 208000019454 Feeding and Eating disease Diseases 0.000 description 1
- 229910002601 GaN Inorganic materials 0.000 description 1
- JMASRVWKEDWRBT-UHFFFAOYSA-N Gallium nitride Chemical compound [Ga]#N JMASRVWKEDWRBT-UHFFFAOYSA-N 0.000 description 1
- 208000003098 Ganglion Cysts Diseases 0.000 description 1
- 208000004454 Hyperalgesia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 208000005615 Interstitial Cystitis Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000489861 Maximus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000016285 Movement disease Diseases 0.000 description 1
- 206010029174 Nerve compression Diseases 0.000 description 1
- 208000000693 Neurogenic Urinary Bladder Diseases 0.000 description 1
- 206010029279 Neurogenic bladder Diseases 0.000 description 1
- 208000009546 Neurogenic bowel Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- 206010040744 Sinus headache Diseases 0.000 description 1
- 206010040840 Skin erosion Diseases 0.000 description 1
- 208000014604 Specific Language disease Diseases 0.000 description 1
- 208000005400 Synovial Cyst Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 description 1
- 101150049278 US20 gene Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000003486 adipose tissue brown Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 206010053552 allodynia Diseases 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 230000009118 appropriate response Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000035581 baroreflex Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000003364 biologic glue Substances 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000002051 biphasic effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 238000011281 clinical therapy Methods 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000037410 cognitive enhancement Effects 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000009850 completed effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000002920 convulsive effect Effects 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000001619 diaphragma pelvis Anatomy 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- HTXDPTMKBJXEOW-UHFFFAOYSA-N dioxoiridium Chemical compound O=[Ir]=O HTXDPTMKBJXEOW-UHFFFAOYSA-N 0.000 description 1
- 235000014632 disordered eating Nutrition 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 201000006517 essential tremor Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000005071 external anal sphincter Anatomy 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000000256 facial nerve Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000002990 hypoglossal effect Effects 0.000 description 1
- 210000001169 hypoglossal nerve Anatomy 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000030214 innervation Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910000457 iridium oxide Inorganic materials 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 238000002684 laminectomy Methods 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000011418 maintenance treatment Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000025350 membrane depolarization involved in regulation of action potential Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000897 modulatory effect Effects 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000003666 myelinated nerve fiber Anatomy 0.000 description 1
- 238000001320 near-infrared absorption spectroscopy Methods 0.000 description 1
- 230000007433 nerve pathway Effects 0.000 description 1
- 230000008904 neural response Effects 0.000 description 1
- 210000004977 neurovascular bundle Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 230000008050 pain signaling Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- HWLDNSXPUQTBOD-UHFFFAOYSA-N platinum-iridium alloy Chemical compound [Ir].[Pt] HWLDNSXPUQTBOD-UHFFFAOYSA-N 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 230000010344 pupil dilation Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 210000002416 recurrent laryngeal nerve Anatomy 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 230000031893 sensory processing Effects 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 238000011301 standard therapy Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 206010046494 urge incontinence Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000003202 urodynamic effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000003966 vascular damage Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0456—Specially adapted for transcutaneous electrical nerve stimulation [TENS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0502—Skin piercing electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0553—Paddle shaped electrodes, e.g. for laminotomy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
- A61N1/0556—Cuff electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36107—Sexual dysfunction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/004—Magnetotherapy specially adapted for a specific therapy
- A61N2/006—Magnetotherapy specially adapted for a specific therapy for magnetic stimulation of nerve tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Reproductive Health (AREA)
- Electrotherapy Devices (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562165037P | 2015-05-21 | 2015-05-21 | |
| US62/165,037 | 2015-05-21 | ||
| US201562171549P | 2015-06-05 | 2015-06-05 | |
| US62/171,549 | 2015-06-05 | ||
| PCT/CA2016/050575 WO2016183689A1 (en) | 2015-05-21 | 2016-05-20 | Systems and methods for treatment of urinary dysfunction |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3114528A Division CA3114528A1 (en) | 2015-05-21 | 2016-05-20 | Systems and methods for treatment of urinary dysfunction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2986467A1 CA2986467A1 (en) | 2016-11-24 |
| CA2986467C true CA2986467C (en) | 2021-06-01 |
Family
ID=57319044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2986467A Active CA2986467C (en) | 2015-05-21 | 2016-05-20 | Systems and methods for treatment of urinary dysfunction |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US9610442B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3297720B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7013023B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107949421B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2016265904B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2986467C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2936070T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016183689A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (121)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8255057B2 (en) | 2009-01-29 | 2012-08-28 | Nevro Corporation | Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions |
| EP2421600B1 (en) | 2009-04-22 | 2014-03-05 | Nevro Corporation | Spinal cord modulation systems for inducing paresthetic and anesthetic effects |
| DE202010018211U1 (de) | 2009-04-22 | 2014-09-29 | Nevro Corporation | Selektive Hochfrequenzrückenmarksmodulation zur Schmerzhemmung mit weniger Nebenwirkung, sowie zugehörige Systeme |
| AU2012304370B2 (en) | 2011-09-08 | 2016-01-28 | Nevro Corporation | Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods |
| EP2776119B1 (en) | 2011-11-11 | 2019-02-06 | The Regents of The University of California | Transcutaneous spinal cord stimulation: noninvasive tool for activation of locomotor circuitry |
| US10201703B2 (en) | 2012-02-02 | 2019-02-12 | The United States Of America, As Represented By The Department Of Veterans Affairs | Integrated surface stimulation device for wound therapy and infection control |
| US9314399B2 (en) | 2012-03-06 | 2016-04-19 | Valencia Technologies Corporation | Implantable electroacupuncture system and method for treating dyslipidemia and obesity |
| US9827421B2 (en) | 2012-03-12 | 2017-11-28 | Valencia Technologies Corporation | Methods and systems for treating a chronic low back pain condition using an implantable electroacupuncture device |
| US12453853B2 (en) | 2013-01-21 | 2025-10-28 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
| CN105142714B (zh) | 2013-01-21 | 2018-02-16 | 卡拉健康公司 | 用于控制震颤的设备和方法 |
| US9993642B2 (en) | 2013-03-15 | 2018-06-12 | The Regents Of The University Of California | Multi-site transcutaneous electrical stimulation of the spinal cord for facilitation of locomotion |
| US9895539B1 (en) | 2013-06-10 | 2018-02-20 | Nevro Corp. | Methods and systems for disease treatment using electrical stimulation |
| EP3049148B1 (en) | 2013-09-27 | 2020-05-20 | The Regents Of The University Of California | Engaging the cervical spinal cord circuitry to re-enable volitional control of hand function in tetraplegic subjects |
| US10149978B1 (en) | 2013-11-07 | 2018-12-11 | Nevro Corp. | Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods |
| BR112016025203B1 (pt) | 2014-06-02 | 2022-09-06 | Cala Health, Inc | Sistema transcutâneo para tratar um paciente que sofre de tremor |
| US12053630B2 (en) | 2014-08-17 | 2024-08-06 | Coloplast A/S | Implantable pulse generator with automatic jump-start |
| EP3180069B1 (en) | 2014-08-17 | 2020-05-13 | Nine Continents Medical, Inc. | Miniature implatable neurostimulator system for sciatic nerves and their branches |
| WO2016029159A2 (en) | 2014-08-21 | 2016-02-25 | The Regents Of The University Of California | Regulation of autonomic control of bladder voiding after a complete spinal cord injury |
| CN106714898A (zh) | 2014-08-26 | 2017-05-24 | 阿文特公司 | 选择性神经纤维阻断方法和系统 |
| AU2015308779B2 (en) | 2014-08-27 | 2020-06-25 | The Regents Of The University Of California | Multi-electrode array for spinal cord epidural stimulation |
| US10328268B2 (en) | 2014-09-04 | 2019-06-25 | AtaCor Medical, Inc. | Cardiac pacing |
| US11097109B2 (en) | 2014-11-24 | 2021-08-24 | AtaCor Medical, Inc. | Cardiac pacing sensing and control |
| JP2018516702A (ja) | 2015-06-10 | 2018-06-28 | カラ ヘルス, インコーポレイテッドCala Health, Inc. | 取り外し可能な治療装置および監視装置で振戦を治療するための末梢神経刺激用のシステムおよび方法 |
| US20180001107A1 (en) | 2016-07-01 | 2018-01-04 | Btl Holdings Limited | Aesthetic method of biological structure treatment by magnetic field |
| EP3331602A4 (en) * | 2015-08-06 | 2019-01-16 | The Regents of The University of California | ELECTRODE ARRANGEMENT FOR THE TRANSCUTANEOUS ELECTRICAL STIMULATION OF THE BACKMARK AND USES THEREOF |
| WO2017035512A1 (en) | 2015-08-26 | 2017-03-02 | The Regents Of The University Of California | Concerted use of noninvasive neuromodulation device with exoskeleton to enable voluntary movement and greater muscle activation when stepping in a chronically paralyzed subject |
| WO2017053847A1 (en) | 2015-09-23 | 2017-03-30 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors |
| US11318310B1 (en) | 2015-10-26 | 2022-05-03 | Nevro Corp. | Neuromodulation for altering autonomic functions, and associated systems and methods |
| US11097122B2 (en) | 2015-11-04 | 2021-08-24 | The Regents Of The University Of California | Magnetic stimulation of the spinal cord to restore control of bladder and/or bowel |
| IL286747B2 (en) | 2016-01-21 | 2024-05-01 | Cala Health Inc | A wearable device for the treatment of symptoms related to the urinary system |
| WO2017132174A1 (en) | 2016-01-25 | 2017-08-03 | Nevro Corp. | Treatment of congestive heart failure with electrical stimulation, and associated systems and methods |
| AU2017212551B2 (en) * | 2016-01-29 | 2021-05-27 | Axonics, Inc. | Methods and systems for frequency adjustment to optimize charging of implantable neurostimulator |
| US11534619B2 (en) | 2016-05-10 | 2022-12-27 | Btl Medical Solutions A.S. | Aesthetic method of biological structure treatment by magnetic field |
| US11141219B1 (en) | 2016-08-16 | 2021-10-12 | BTL Healthcare Technologies, a.s. | Self-operating belt |
| CN117959601A (zh) | 2016-08-25 | 2024-05-03 | 卡拉健康公司 | 通过周围神经刺激治疗心脏机能障碍的系统和方法 |
| US10737091B2 (en) * | 2016-11-01 | 2020-08-11 | Precisis Ag | Electrode and electrode pad for the electrical stimulation of brain tissue or other tissue of a patient |
| US11571574B2 (en) * | 2016-11-11 | 2023-02-07 | Galvani Bioelectronics Limited | Treatment of diseases mediated by thyroid and parathyroid hormones |
| EP3551280B1 (en) * | 2016-12-12 | 2023-08-09 | The Regents of the University of California | Implantable and non-invasive stimulators for gastrointestinal therapeutics |
| US10966754B2 (en) | 2017-01-17 | 2021-04-06 | Avation Medical, Inc. | Devices, systems, and methods for delivery of electrical microstimulators |
| US10220214B2 (en) | 2017-01-17 | 2019-03-05 | Veressa Medical, Inc. | Devices, systems, and methods for improving pelvic floor dysfunction |
| EP3570937A1 (en) * | 2017-01-17 | 2019-11-27 | Avation Medical, Inc. | System for identifying a target medical device implant site |
| EP4473909A3 (en) | 2017-02-17 | 2025-01-29 | The University of British Columbia | Apparatus and methods for maintaining physiological functions |
| CA3058786A1 (en) * | 2017-04-03 | 2018-10-11 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| US11896823B2 (en) | 2017-04-04 | 2024-02-13 | Btl Healthcare Technologies A.S. | Method and device for pelvic floor tissue treatment |
| US11285318B2 (en) | 2017-05-04 | 2022-03-29 | University of Pittsburgh—of the Commonwealth System of Higher Education | Peripheral neuromodulation to treat bladder and bowel dysfunction |
| WO2018217791A1 (en) * | 2017-05-23 | 2018-11-29 | The Regents Of The University Of California | Accessing spinal networks to address sexual dysfunction |
| ES3042380T3 (en) | 2017-06-22 | 2025-11-20 | Checkpoint Surgical Inc | Nerve regeneration system |
| EP3974021B1 (en) | 2017-06-30 | 2023-06-14 | ONWARD Medical N.V. | A system for neuromodulation |
| US11135428B2 (en) | 2017-07-02 | 2021-10-05 | Ebt Medical, Inc. | Systems and methods for providing patient signaling and contingent stimulation |
| US11723579B2 (en) | 2017-09-19 | 2023-08-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
| US11458309B2 (en) | 2017-09-19 | 2022-10-04 | United States Government As Represented By The Department Of Veterans Affairs | Flexible implantable tissue stimulator and methods of making and using same |
| EP3881788B1 (en) | 2017-10-24 | 2022-11-16 | St. Jude Medical, Cardiology Division, Inc. | System for determining contact status of a medical device with tissue |
| CN111511435A (zh) | 2017-10-25 | 2020-08-07 | 艾品诺龙科技公司 | 用于递送神经再生疗法的系统和方法 |
| US10589089B2 (en) | 2017-10-25 | 2020-03-17 | Epineuron Technologies Inc. | Systems and methods for delivering neuroregenerative therapy |
| US11305113B2 (en) * | 2017-11-11 | 2022-04-19 | Neurostim Solutions LLC | Nocturia reduction system |
| ES2768106T3 (es) | 2017-12-04 | 2020-06-19 | Synergia Medical | Un electrodo o un optodo de manguito implantable que comprende bordes blandos y su proceso de fabricación |
| US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
| US11992684B2 (en) | 2017-12-05 | 2024-05-28 | Ecole Polytechnique Federale De Lausanne (Epfl) | System for planning and/or providing neuromodulation |
| US12357828B2 (en) | 2017-12-05 | 2025-07-15 | Ecole Polytechnique Federale De Lausanne (Epfl) | System for planning and/or providing neuromodulation |
| US11298546B2 (en) * | 2017-12-12 | 2022-04-12 | Duke University | Systems and methods for minimizing response variability of spinal cord stimulation |
| US12280219B2 (en) | 2017-12-31 | 2025-04-22 | NeuroLight, Inc. | Method and apparatus for neuroenhancement to enhance emotional response |
| US11318277B2 (en) | 2017-12-31 | 2022-05-03 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
| EP3740274A4 (en) * | 2018-01-17 | 2021-10-27 | Cala Health, Inc. | SYSTEMS AND METHODS FOR TREATING INFLAMMATORY INTESTINAL DISEASE USING PERIPHERAL NERVE STIMULATION |
| AU2019223992B2 (en) * | 2018-02-20 | 2022-03-10 | University Of Iowa Research Foundation | Therapeutic systems using magnetic and electric fields |
| US10780270B2 (en) * | 2018-03-15 | 2020-09-22 | Avent, Inc. | System and method to percutaneously block painful sensations |
| EP3768349A4 (en) | 2018-03-20 | 2021-12-29 | Second Heart Assist, Inc. | Circulatory assist pump |
| US12491356B2 (en) | 2018-03-20 | 2025-12-09 | Second Heart Assist, Inc. | Circulatory assist pump |
| US12415077B2 (en) * | 2018-04-03 | 2025-09-16 | Livanova Usa, Inc. | User interface for titration assist |
| WO2019200270A1 (en) * | 2018-04-12 | 2019-10-17 | Robinson David J | Devices and methods for improving headache disorders |
| US10363414B1 (en) * | 2018-04-12 | 2019-07-30 | Feinstein Patents, Llc | Combined bladder scanner and (functional) interferential electrical stimulation device |
| KR20210016346A (ko) | 2018-04-19 | 2021-02-15 | 아이오타 바이오사이언시즈 인코퍼레이티드 | 비장 신경 활동을 조절하기 위해 초음파 통신을 사용하는 이식물 |
| MX2020011010A (es) | 2018-04-19 | 2021-01-20 | Iota Biosciences Inc | Implantes utilizando comunicación ultrasónica para detección y estimulación neuronales. |
| US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
| US10493272B1 (en) * | 2018-06-01 | 2019-12-03 | Feinstein Patents, Llc | Inferential electrical stimulation device with targeting capabilities |
| CN108853717B (zh) * | 2018-06-19 | 2022-03-22 | 国家纳米科学中心 | 一种柔性神经电极以及柔性神经电极的植入方法 |
| EP3813647A4 (en) * | 2018-06-27 | 2022-03-09 | Cala Health, Inc. | MULTIMODAL STIMULATION FOR TREMOR TREATMENT |
| US11109821B2 (en) | 2018-07-06 | 2021-09-07 | Melanie CRITES-BACHERT | Method for needle positioning and lead implantation for sacral neuromodulation |
| US20200016396A1 (en) * | 2018-07-11 | 2020-01-16 | Synchron Australia Pty Limited | Systems and methods for improving placement of devices for neural stimulation |
| EP3820563B1 (en) * | 2018-07-11 | 2025-10-01 | Dignify Therapeutics, LLC | Stimulator device for use in controlling waste storage for a patient |
| US11464964B2 (en) * | 2018-08-03 | 2022-10-11 | Brown University | Neural interrogation platform |
| EP3840638A4 (en) | 2018-08-23 | 2022-05-18 | The Regents Of The University Of California | NON-INVASIVE SPINAL CORD STIMULATION FOR NERVE ROOT PALSY, CAUDA SYNDROME AND RESTORATION OF FUNCTION OF THE UPPER EXTREMITIES |
| CA3109810A1 (en) | 2018-08-29 | 2020-03-05 | Jose M. Carmena | Implantable closed-loop neuromodulation device, systems, and methods of use |
| EP3843831B1 (en) | 2018-08-31 | 2022-10-19 | Avation Medical, Inc. | System, method, and apparatus for applying transcutaneous electrical stimulation |
| EP3849410A4 (en) | 2018-09-14 | 2022-11-02 | Neuroenhancement Lab, LLC | System and method of improving sleep |
| CN109199359A (zh) * | 2018-10-15 | 2019-01-15 | 暨南大学 | 光电联合刺激系统和光电联合刺激神经纤维方法 |
| ES2911465T3 (es) | 2018-11-13 | 2022-05-19 | Onward Medical N V | Sistema de control para la reconstrucción y/o restauración del movimiento de un paciente |
| US11590352B2 (en) | 2019-01-29 | 2023-02-28 | Nevro Corp. | Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods |
| EP3695878B1 (en) | 2019-02-12 | 2023-04-19 | ONWARD Medical N.V. | A system for neuromodulation |
| AU2019433228B2 (en) | 2019-03-11 | 2021-09-16 | Synergia Medical | Cuff electrode or optrode comprising a handling flap |
| KR102609208B1 (ko) | 2019-04-11 | 2023-12-05 | 비티엘 메디컬 솔루션스 에이.에스. | 고주파 및 자기 에너지에 의한 생물학적 구조들의 심미적 치료를 위한 방법들 및 디바이스들 |
| US12156689B2 (en) | 2019-04-11 | 2024-12-03 | Btl Medical Solutions A.S. | Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US11446495B2 (en) * | 2019-05-14 | 2022-09-20 | Twenty Twenty Therapeutics Llc | Therapeutic devices for placement underneath the eyelid and associated systems, devices, and methods for dry eye treatment |
| EP3976167A1 (en) | 2019-05-29 | 2022-04-06 | Atacor Medical, Inc. | Implantable electrical leads and associated delivery systems |
| CN114286705A (zh) * | 2019-07-03 | 2022-04-05 | 高等教育联邦系统-匹兹堡大学 | 利用超阈值低频电刺激的神经阻滞 |
| US12337173B2 (en) | 2019-07-30 | 2025-06-24 | Duke University | Devices, systems, and methods for promoting voiding in subjects with underactive bladders |
| US12251560B1 (en) | 2019-08-13 | 2025-03-18 | Cala Health, Inc. | Connection quality determination for wearable neurostimulation systems |
| CN110559554A (zh) * | 2019-08-22 | 2019-12-13 | 西安八水健康科技有限公司 | 一种融合经颅电刺激和迷走神经刺激的电刺激装置 |
| US11364381B2 (en) | 2019-10-01 | 2022-06-21 | Epineuron Technologies Inc. | Methods for delivering neuroregenerative therapy and reducing post-operative and chronic pain |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| AU2020366508A1 (en) * | 2019-10-17 | 2022-04-21 | Iota Biosciences, Inc. | Helical nerve cuff and related implantable devices |
| EP4045136A4 (en) | 2019-10-17 | 2023-11-08 | Iota Biosciences, Inc. | Devices and methods for modulating immune system activity in a cancer patient and treating cancer |
| US11648405B2 (en) * | 2019-11-01 | 2023-05-16 | Resolute 360, LLC | Percutaneous nerve evaluation for sacral neuromodulation |
| EP3827875B1 (en) | 2019-11-27 | 2023-07-05 | ONWARD Medical N.V. | Neuromodulation system |
| DE19211698T1 (de) | 2019-11-27 | 2021-09-02 | Onward Medical B.V. | Neuromodulation system |
| FR3106280B1 (fr) * | 2020-01-22 | 2024-05-03 | Stimuli Tech | Dispositif portatif non invasif de stimulation nerveuse électrique |
| ES2993637T3 (en) | 2020-05-04 | 2025-01-03 | Btl Healthcare Technologies As | Device for unattended treatment of a patient |
| US11878167B2 (en) | 2020-05-04 | 2024-01-23 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| CN111529887B (zh) * | 2020-05-12 | 2022-08-19 | 上海交通大学医学院附属上海儿童医学中心 | 尿意放松训练装置 |
| US11666771B2 (en) * | 2020-05-29 | 2023-06-06 | AtaCor Medical, Inc. | Implantable electrical leads and associated delivery systems |
| WO2022109792A1 (zh) * | 2020-11-24 | 2022-06-02 | 中国科学院深圳先进技术研究院 | 闭环超声刺激控制排尿功能的装置 |
| CN112494831B (zh) * | 2020-11-24 | 2023-03-31 | 中国科学院深圳先进技术研究院 | 闭环超声刺激控制排尿功能的装置 |
| JP2024513688A (ja) * | 2021-03-12 | 2024-03-27 | アンバー セラピューティクス リミテッド | 失禁制御のためのデバイス、システム、および方法 |
| GB2620336A (en) * | 2021-03-22 | 2024-01-03 | Magnus Medical Inc | System and method for determining a treatment schedule |
| EP4415812A1 (en) | 2021-10-13 | 2024-08-21 | BTL Medical Solutions a.s. | Devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy |
| US11896816B2 (en) | 2021-11-03 | 2024-02-13 | Btl Healthcare Technologies A.S. | Device and method for unattended treatment of a patient |
| US20230141622A1 (en) * | 2021-11-09 | 2023-05-11 | Medtronic, Inc. | Minimally invasive neurostimulation device with sensing capability |
| EP4436497A1 (en) | 2021-11-24 | 2024-10-02 | Atacor Medical, Inc. | Implantable electrical leads and associated delivery and control systems |
| CA3249894A1 (en) * | 2022-02-28 | 2023-08-31 | The Regents Of The University Of Michigan | SYSTEMS AND METHODS FOR CONTROLLING A PROSTHESIS USING AMPLIFIED NERVE SIGNALS |
| CN116459447A (zh) * | 2023-04-07 | 2023-07-21 | 上海骊霄医疗技术有限公司 | 一种胫神经刺激系统及其刺激波形 |
| WO2024258812A1 (en) * | 2023-06-13 | 2024-12-19 | Sonostics, Inc. | Apparatus, system and method using magnetic nerve modulation for treatment of reduced cardiac output in the human and methods related thereto |
| KR102774529B1 (ko) * | 2024-12-31 | 2025-03-05 | (주)아주르852 | 출산 준비기 산모의 골반저 영역 검사를 기반으로 한 맞춤형 케어 시스템 |
Family Cites Families (92)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5193539A (en) | 1991-12-18 | 1993-03-16 | Alfred E. Mann Foundation For Scientific Research | Implantable microstimulator |
| US6493588B1 (en) | 1998-03-18 | 2002-12-10 | Mmc/Gatx Partnership No. 1 | Electro-nerve stimulator systems and methods |
| US6941171B2 (en) | 1998-07-06 | 2005-09-06 | Advanced Bionics Corporation | Implantable stimulator methods for treatment of incontinence and pain |
| US6205359B1 (en) | 1998-10-26 | 2001-03-20 | Birinder Bob Boveja | Apparatus and method for adjunct (add-on) therapy of partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator |
| US20010025192A1 (en) | 1999-04-29 | 2001-09-27 | Medtronic, Inc. | Single and multi-polar implantable lead for sacral nerve electrical stimulation |
| US6314324B1 (en) | 1999-05-05 | 2001-11-06 | Respironics, Inc. | Vestibular stimulation system and method |
| US6272383B1 (en) | 1999-06-28 | 2001-08-07 | Woodside Biomedical, Inc. | Electro-acupuncture method using an electrical stimulator |
| US6885888B2 (en) | 2000-01-20 | 2005-04-26 | The Cleveland Clinic Foundation | Electrical stimulation of the sympathetic nerve chain |
| AU3361901A (en) | 2000-02-17 | 2001-08-27 | Neurodan A/S | Methods and implantable systems for neural sensing and nerve stimulation |
| US6453204B1 (en) | 2000-08-11 | 2002-09-17 | Donald A. Rhodes | Magnetic electrode for delivering energy to the body |
| US7054689B1 (en) | 2000-08-18 | 2006-05-30 | Advanced Bionics Corporation | Fully implantable neurostimulator for autonomic nerve fiber stimulation as a therapy for urinary and bowel dysfunction |
| US20050143789A1 (en) | 2001-01-30 | 2005-06-30 | Whitehurst Todd K. | Methods and systems for stimulating a peripheral nerve to treat chronic pain |
| CA2926344C (en) | 2001-10-17 | 2018-06-19 | Compex Technologies, Inc. | Electrical nerve stimulation stimulator |
| US8812114B2 (en) | 2001-10-18 | 2014-08-19 | Uroplasty, Inc. | Lead set for nerve stimulator and method of operation thereof |
| US6993392B2 (en) | 2002-03-14 | 2006-01-31 | Duke University | Miniaturized high-density multichannel electrode array for long-term neuronal recordings |
| AU2003236525A1 (en) | 2002-06-12 | 2003-12-31 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Injection devices and methods for testing implants and for unimpeded target location testing |
| AU2003265509A1 (en) | 2002-08-19 | 2004-03-03 | Arizona Board Regents | Neurostimulator |
| TR200202651A2 (tr) | 2002-12-12 | 2004-07-21 | Met�N�Tulgar | VücutÁdışındanÁdirekÁtedaviÁsinyaliÁtransferliÁÁbeyinÁpili |
| US20040122477A1 (en) | 2002-12-19 | 2004-06-24 | Whitehurst Todd K. | Fully implantable miniature neurostimulator for spinal nerve root stimulation as a therapy for angina and peripheral vascular disease |
| US7294101B2 (en) | 2002-12-21 | 2007-11-13 | Neuropace, Inc. | Means and methods for treating headaches |
| CN1767872B (zh) | 2003-04-02 | 2010-12-08 | 神经技术无限责任公司 | 治疗足下垂及其它神经疾病的植入式神经信号传感刺激装置 |
| US20040204962A1 (en) | 2003-04-14 | 2004-10-14 | Howser Steven Joseph | Automated patient compliancy monitoring system and method |
| US20090198293A1 (en) | 2003-12-19 | 2009-08-06 | Lawrence Cauller | Microtransponder Array for Implant |
| JP4879754B2 (ja) | 2004-01-22 | 2012-02-22 | リハブトロニクス インコーポレーテッド | 移植された非活性導電体を介して、身体組織に電流を搬送する方法 |
| US8751003B2 (en) | 2004-02-11 | 2014-06-10 | Ethicon, Inc. | Conductive mesh for neurostimulation |
| US7395113B2 (en) | 2004-03-16 | 2008-07-01 | Medtronic, Inc. | Collecting activity information to evaluate therapy |
| US8052591B2 (en) | 2006-05-05 | 2011-11-08 | The Board Of Trustees Of The Leland Stanford Junior University | Trajectory-based deep-brain stereotactic transcranial magnetic stimulation |
| US7729772B2 (en) | 2005-01-07 | 2010-06-01 | Uroplasty, Inc. | Implantable neuromodulation system and method |
| JP5249024B2 (ja) | 2005-06-28 | 2013-07-31 | バイオネス インコーポレイテッド | 電流を通す埋込み受動導体を使用するインプラント、システムおよび方法に対する改良 |
| US8012189B1 (en) | 2007-01-11 | 2011-09-06 | Lockheed Martin Corporation | Method and vestibular implant using optical stimulation of nerves |
| US8676324B2 (en) | 2005-11-10 | 2014-03-18 | ElectroCore, LLC | Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders |
| US8874227B2 (en) * | 2009-03-20 | 2014-10-28 | ElectroCore, LLC | Devices and methods for non-invasive capacitive electrical stimulation and their use for vagus nerve stimulation on the neck of a patient |
| US8041428B2 (en) | 2006-02-10 | 2011-10-18 | Electrocore Llc | Electrical stimulation treatment of hypotension |
| US8262556B2 (en) | 2005-12-19 | 2012-09-11 | Neuralieve, Inc. | Magnetic pulsing system for inducing electric currents in a human body |
| US9339641B2 (en) | 2006-01-17 | 2016-05-17 | Emkinetics, Inc. | Method and apparatus for transdermal stimulation over the palmar and plantar surfaces |
| AU2007207297B2 (en) | 2006-01-23 | 2011-12-22 | 2249020 Alberta Ltd. | Method of routing electrical current to bodily tissues via implanted passive conductors |
| AU2006337679A1 (en) | 2006-02-10 | 2007-08-16 | Electrocore, Inc. | Methods and apparatus for treating anaphylaxis using electrical modulation |
| US8135476B2 (en) | 2006-04-27 | 2012-03-13 | Medtronic, Inc. | Implantable medical electrical stimulation lead fixation method and apparatus |
| DK2024006T3 (en) | 2006-05-18 | 2019-02-04 | Uroplasty Inc | Apparatus for stimulation of a patient's nerve |
| JP2010505471A (ja) | 2006-10-02 | 2010-02-25 | エムキネティクス， インコーポレイテッド | 磁気誘導療法のための方法および装置 |
| US20080154334A1 (en) | 2006-12-26 | 2008-06-26 | Stas Gavronsky | Method of pain relief in patients after abdominal/pelvic surgery |
| CN201001835Y (zh) * | 2007-02-05 | 2008-01-09 | 李静 | 防治妇产科术后并发症的电动按摩袜 |
| EP2146660B1 (en) | 2007-04-19 | 2015-07-29 | Mectron S.p.A. | Ultrasound frequency resonant dipole for medical use |
| US9597029B2 (en) | 2007-06-19 | 2017-03-21 | Cardiac Pacemakers, Inc. | System and method for remotely evaluating patient compliance status |
| US8116882B2 (en) | 2008-02-15 | 2012-02-14 | Angeltear Solutions Inc. | Adjustable tissue or nerve cuff and method of use |
| US20090326602A1 (en) | 2008-06-27 | 2009-12-31 | Arkady Glukhovsky | Treatment of indications using electrical stimulation |
| WO2010006049A1 (en) | 2008-07-08 | 2010-01-14 | The Board Of Trustees Of The Leland Stanford Junior University | Materials and approaches for optical stimulation of the peripheral nervous system |
| ES2736276T3 (es) | 2008-07-14 | 2019-12-27 | Arizona Board Of Regents For And On Behalf Of Arizona State Univ | Dispositivos de modulación de la actividad celular utilizando ultrasonido |
| US8634932B1 (en) | 2008-07-21 | 2014-01-21 | Greatbatch Ltd. | Minimally invasive methods for implanting a sacral stimulation lead |
| US20130317281A1 (en) | 2010-10-08 | 2013-11-28 | M. Bret Schneider | Transcranial magnetic stimulation for improved analgesia |
| WO2010065143A1 (en) * | 2008-12-05 | 2010-06-10 | Ndi Medical, Llc | Systems and methods to place one or more leads in tissue for providing functional and/or therapeutic stimulation |
| AU2010215784B2 (en) | 2009-02-20 | 2015-04-30 | Sage Products, Llc | Systems and methods of powered muscle stimulation using an energy guidance field |
| US9375571B2 (en) | 2013-01-15 | 2016-06-28 | ElectroCore, LLC | Mobile phone using non-invasive nerve stimulation |
| US10232178B2 (en) | 2009-03-20 | 2019-03-19 | Electrocore, Inc. | Non-invasive magnetic or electrical nerve stimulation to treat or prevent dementia |
| US9174045B2 (en) | 2009-03-20 | 2015-11-03 | ElectroCore, LLC | Non-invasive electrical and magnetic nerve stimulators used to treat overactive bladder and urinary incontinence |
| US8715327B1 (en) | 2009-04-13 | 2014-05-06 | Cvrx, Inc. | Baroreflex modulation using light-based stimulation |
| JP5711221B2 (ja) | 2009-05-15 | 2015-04-30 | スパイナル・モデュレーション・インコーポレイテッドＳｐｉｎａｌ Ｍｏｄｕｌａｔｉｏｎ Ｉｎｃ． | 脊髄組織を神経調節する方法、システム、およびデバイス |
| US8909343B2 (en) | 2009-05-22 | 2014-12-09 | Arizona Board Of Regents On Behalf Of Arizona State University | Systems, and methods for neurostimulation and neurotelemetry using semiconductor diode systems |
| US8509920B2 (en) | 2009-06-19 | 2013-08-13 | Medtronic, Inc. | Electrode arrangements for medical lead |
| WO2011019933A1 (en) | 2009-08-12 | 2011-02-17 | Medtronic, Inc. | Dorsal column stimulation therapy |
| WO2011033750A1 (ja) | 2009-09-17 | 2011-03-24 | パナソニック株式会社 | 排尿障害治療器 |
| WO2011041526A2 (en) * | 2009-10-01 | 2011-04-07 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Non-invasive method to treat urological and gastrointestinal disorders |
| CN102686271A (zh) | 2009-11-10 | 2012-09-19 | 伊姆特拉医疗公司 | 用于刺激舌下神经以控制患者的舌头的位置的系统 |
| US8956277B2 (en) | 2010-02-28 | 2015-02-17 | David J. Mishelevich | Stimulation method via deep brain stimulation |
| US20110270138A1 (en) | 2010-05-02 | 2011-11-03 | Mishelevich David J | Ultrasound macro-pulse and micro-pulse shapes for neuromodulation |
| US20140194726A1 (en) | 2013-01-04 | 2014-07-10 | Neurotrek, Inc. | Ultrasound Neuromodulation for Cognitive Enhancement |
| US20110190668A1 (en) | 2010-02-03 | 2011-08-04 | Mishelevich David J | Ultrasound neuromodulation of the sphenopalatine ganglion |
| US8788045B2 (en) | 2010-06-08 | 2014-07-22 | Bluewind Medical Ltd. | Tibial nerve stimulation |
| GB201009977D0 (en) * | 2010-06-15 | 2010-07-21 | Sky Medical Technology Ltd | Incontinence treatment |
| WO2012082979A2 (en) | 2010-12-15 | 2012-06-21 | Ams Research Corporation | Tibial nerve stimulation |
| US9220897B2 (en) | 2011-04-04 | 2015-12-29 | Micron Devices Llc | Implantable lead |
| JP2012217565A (ja) * | 2011-04-07 | 2012-11-12 | Panasonic Corp | 排尿障害治療装置 |
| JP2014527416A (ja) | 2011-06-16 | 2014-10-16 | アドバンスト・ユーロ−ソリューションズ，エルエルシー | 経皮的脛骨神経刺激器 |
| US9066845B2 (en) | 2012-03-06 | 2015-06-30 | Valencia Technologies Corporation | Electrode configuration for an implantable electroacupuncture device |
| US8785112B2 (en) | 2011-09-24 | 2014-07-22 | Global Foundries Inc. | Reticle defect correction by second exposure |
| AU2012313964B2 (en) | 2011-09-30 | 2017-05-25 | Nyxoah SA | Apparatus and methods for feedback-based nerve modulation |
| EP2574368B1 (fr) | 2011-09-30 | 2014-12-24 | Sorin CRM SAS | Sonde de stimulation épicardique multizone |
| US9827420B2 (en) | 2013-03-29 | 2017-11-28 | Neurometrix, Inc. | Transcutaneous electrical nerve stimulator with user gesture detector and electrode-skin contact detector, with transient motion detector for increasing the accuracy of the same |
| US20130150696A1 (en) | 2011-12-12 | 2013-06-13 | Huntington Medical Research Institutes | Hybrid multielectrode arrays |
| US9089716B2 (en) | 2012-03-12 | 2015-07-28 | Valencia Technologies Corporation | Circuits and methods for using a high impedance, thin, coin-cell type battery in an implantable electroacupuncture device |
| US8918175B2 (en) | 2012-04-23 | 2014-12-23 | Medtronic, Inc. | Electrical stimulation therapy for lower urinary tract dysfunction and sexual reflex dysfunction |
| US8903499B2 (en) | 2012-05-21 | 2014-12-02 | Autonomic Technologies, Inc. | Neurostimulator system apparatus and method |
| WO2014153219A1 (en) | 2013-03-14 | 2014-09-25 | Perryman Laura Tyler | Devices and methods for treating urological disorders |
| AU2013305543A1 (en) * | 2012-08-23 | 2015-03-19 | Endostim, Inc. | Device and implantation system for electrical stimulation of biological systems |
| JP6069507B2 (ja) | 2012-09-19 | 2017-02-01 | カーディアック ペースメイカーズ， インコーポレイテッド | 暫定的埋め込み型の電気刺激リード線用の固定機構 |
| US9724512B2 (en) | 2012-09-28 | 2017-08-08 | Valencia Technologies Corporation | Implantable electroacupuncture system and method for treating parkinson's disease and essential tremor through application of stimului at or near an acupoint on the chorea line |
| US9084897B2 (en) | 2012-11-20 | 2015-07-21 | Ams Research Corporation | Tibial nerve stimulation therapy device calibration |
| WO2014127091A1 (en) | 2013-02-14 | 2014-08-21 | Thync, Inc. | Transcranial ultrasound systems |
| CN105392522B (zh) | 2013-05-14 | 2017-09-22 | 波士顿科学神经调制公司 | 具有锚固单元和电极布置的电刺激引线以及其制造和使用方法 |
| EP3077046B1 (en) * | 2013-11-27 | 2021-08-18 | EBT Medical, Inc. | Systems for enhancing electrical activation of nervous tissue |
| EP3237057B1 (en) | 2014-12-23 | 2022-08-24 | University of Pittsburgh - Of the Commonwealth System of Higher Education | Devices and systems for treating urological and gastrointestinal disorders by electrical stimulation of the foot |
| EP3347085B1 (en) | 2015-09-11 | 2023-07-26 | Nalu Medical, Inc. | Apparatus for peripheral or spinal stimulation |
-
2016
- 2016-05-20 WO PCT/CA2016/050575 patent/WO2016183689A1/en not_active Ceased
- 2016-05-20 AU AU2016265904A patent/AU2016265904B2/en active Active
- 2016-05-20 EP EP16795603.6A patent/EP3297720B1/en active Active
- 2016-05-20 CA CA2986467A patent/CA2986467C/en active Active
- 2016-05-20 ES ES16795603T patent/ES2936070T3/es active Active
- 2016-05-20 JP JP2018512457A patent/JP7013023B2/ja active Active
- 2016-05-20 US US15/160,468 patent/US9610442B2/en active Active
- 2016-05-20 CN CN201680042787.5A patent/CN107949421B/zh active Active
-
2017
- 2017-02-22 US US15/439,415 patent/US9884187B2/en active Active
- 2017-12-27 US US15/855,117 patent/US10722709B2/en active Active
-
2020
- 2020-06-23 US US16/946,458 patent/US11446489B2/en active Active
-
2021
- 2021-03-31 US US17/301,334 patent/US11752334B2/en active Active
-
2022
- 2022-01-12 JP JP2022003136A patent/JP7231964B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7231964B2 (ja) | 2023-03-02 |
| CA2986467A1 (en) | 2016-11-24 |
| CN107949421A (zh) | 2018-04-20 |
| JP7013023B2 (ja) | 2022-01-31 |
| US11752334B2 (en) | 2023-09-12 |
| EP3297720A4 (en) | 2019-01-23 |
| AU2016265904A1 (en) | 2017-12-21 |
| US9610442B2 (en) | 2017-04-04 |
| US20210213283A1 (en) | 2021-07-15 |
| WO2016183689A1 (en) | 2016-11-24 |
| US20160339239A1 (en) | 2016-11-24 |
| US20170304614A1 (en) | 2017-10-26 |
| US11446489B2 (en) | 2022-09-20 |
| US10722709B2 (en) | 2020-07-28 |
| JP2018521813A (ja) | 2018-08-09 |
| AU2016265904B2 (en) | 2021-04-08 |
| EP3297720A1 (en) | 2018-03-28 |
| CN107949421B (zh) | 2021-05-04 |
| JP2022046777A (ja) | 2022-03-23 |
| US20180133473A1 (en) | 2018-05-17 |
| US20200316379A1 (en) | 2020-10-08 |
| ES2936070T3 (es) | 2023-03-14 |
| EP3297720B1 (en) | 2022-11-02 |
| US9884187B2 (en) | 2018-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11752334B2 (en) | Method for treating a patient having a pelvic floor dysfunction | |
| US11529513B2 (en) | Neuromodulation system | |
| US12290681B1 (en) | Electrical neurostimulation treatment of overactive bladder | |
| US11633593B2 (en) | Treatment of pelvic floor disorders using targeted lower limb nerve stimulation | |
| CA2931799C (en) | Systems and methods of enhancing electrical activation of nervous tissue | |
| US11998738B2 (en) | Neuromodulation system | |
| US12447336B2 (en) | Treatment of overactive bladder with phase-contingent pudendal nerve stimulation | |
| US20230256244A1 (en) | Treatment of pelvic floor disorders using targeted lower limb nerve stimulation | |
| CA3114528A1 (en) | Systems and methods for treatment of urinary dysfunction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20180305 |
|
| EEER | Examination request |
Effective date: 20180305 |